Literature DB >> 10687996

Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients.

R Hull1, D Rudy, W Donovan, C Svanborg, I Wieser, C Stewart, R Darouiche.   

Abstract

PURPOSE: Escherichia coli 83972 was previously shown to establish bladder colonization in select patient groups. We evaluate the safety and feasibility of using bacterial interference with E. coli 83972 to prevent urinary tract infection in spinal cord injured patients.
MATERIALS AND METHODS: A total of 21 men and women with neurogenic bladder secondary to spinal cord injury underwent intravesical inoculation with E. coli 83972. Frequency of symptomatic urinary tract infection before and after colonization was compared.
RESULTS: Successful long-term bladder colonization was achieved in 13 study participants. Mean duration of colonization was 12.3 months (range 2 to 40). Subjects had no symptoms of urinary tract infection while colonized with E. coli 83972 (0 infection per 18.4 patient-years). Successfully colonized subjects had experienced a mean of 3.1 symptomatic urinary tract infections per year (range 2 to 7) before colonization. Symptomatic infection also occurred in 4 subjects who were not successfully colonized with E. coli 83972 and in 7 others after spontaneous loss of colonization. Colonized subjects reported subjective improvement in quality of life with respect to urinary tract infection while colonized.
CONCLUSIONS: E. coli 83972 may be safely used to establish long-term asymptomatic bladder colonization in spinal cord injured subjects. Preliminary findings suggest that colonization with E. coli 83972 may reduce the frequency of urinary tract infection in patients with neurogenic bladder secondary to spinal cord injury.

Entities:  

Mesh:

Year:  2000        PMID: 10687996

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  50 in total

1.  Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli.

Authors:  Rebecca E Watts; Makrina Totsika; Victoria L Challinor; Amanda N Mabbett; Glen C Ulett; James J De Voss; Mark A Schembri
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 2.  Catheter-associated infections: pathogenesis affects prevention.

Authors:  Barbara W Trautner; Rabih O Darouiche
Journal:  Arch Intern Med       Date:  2004-04-26

3.  Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation.

Authors:  Viktoria Hancock; Rebecca Munk Vejborg; Per Klemm
Journal:  Mol Genet Genomics       Date:  2010-10-01       Impact factor: 3.291

Review 4.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

5.  Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen.

Authors:  Per Klemm; Viktoria Roos; Glen C Ulett; Catharina Svanborg; Mark A Schembri
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition.

Authors:  Scott A Beatson; Nouri L Ben Zakour; Makrina Totsika; Brian M Forde; Rebecca E Watts; Amanda N Mabbett; Jan M Szubert; Sohinee Sarkar; Minh-Duy Phan; Kate M Peters; Nicola K Petty; Nabil-Fareed Alikhan; Mitchell J Sullivan; Jayde A Gawthorne; Mitchell Stanton-Cook; Nguyen Thi Khanh Nhu; Teik Min Chong; Wai-Fong Yin; Kok-Gan Chan; Viktoria Hancock; David W Ussery; Glen C Ulett; Mark A Schembri
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

Review 7.  Genetics of innate immunity and UTI susceptibility.

Authors:  Bryndís Ragnarsdóttir; Nataliya Lutay; Jenny Grönberg-Hernandez; Bela Köves; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2011-07-12       Impact factor: 14.432

8.  Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens.

Authors:  Barbara W Trautner; Richard A Hull; Rabih O Darouiche
Journal:  Urology       Date:  2003-05       Impact factor: 2.649

9.  The human microbiome and probiotics: implications for pediatrics.

Authors:  Michael H Hsieh; James Versalovic
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2008 Nov-Dec

Review 10.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.